MYC and Miyoshi myopathy: To the best of our knowledge, we are the first to demonstrate that the retinoid adapalene inhibited MM cells by suppressing c-MYC, suggesting a novel mode of action of adapalene not as an anti-inflammatory but as a potential anticancer agent.